The comparison between fixed versus degressive doses of medroxyprogesterone acetate combined with letrozole in patients of progestin-primed ovarian stimulation protocol: a propensity score-matched study

MLA

Ying Zhang, et al. “The Comparison between Fixed versus Degressive Doses of Medroxyprogesterone Acetate Combined with Letrozole in Patients of Progestin-Primed Ovarian Stimulation Protocol: A Propensity Score-Matched Study.” Frontiers in Endocrinology, vol. 14, Dec. 2023. EBSCOhost, https://doi.org/10.3389/fendo.2023.1295787.

APA

Ying Zhang, Hao Li, Shanshan Zhu, Shengfang Jiang, Wenxian Zhao, Xiaoning Wang, Liu Tian, Guangming Zhao, Nongqiao He, Honglu Diao, Hong Cao, & Changjun Zhang. (2023). The comparison between fixed versus degressive doses of medroxyprogesterone acetate combined with letrozole in patients of progestin-primed ovarian stimulation protocol: a propensity score-matched study. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1295787

Chicago

Ying Zhang, Hao Li, Shanshan Zhu, Shengfang Jiang, Wenxian Zhao, Xiaoning Wang, Liu Tian, et al. 2023. “The Comparison between Fixed versus Degressive Doses of Medroxyprogesterone Acetate Combined with Letrozole in Patients of Progestin-Primed Ovarian Stimulation Protocol: A Propensity Score-Matched Study.” Frontiers in Endocrinology 14 (December). doi:10.3389/fendo.2023.1295787.